Fungal KATs/KDACs: A New Highway to Better Antifungal Drugs?

PLoS Pathogens

Volumn 12, Issue 11, 2016, Pages

  Kuchler, Karl ^a   Jenull, Sabrina ^a   Shivarathri, Raju ^a   Chauhan, Neeraj ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE ACETYLTRANSFERASE; LYSINE DEACETYLASE; LYSINE DERIVATIVE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; FUNGAL PROTEIN; HISTONE DEMETHYLASE;

FUNGAL VIRULENCE; GENE CONTROL; GENE EXPRESSION; HISTONE MODIFICATION; HISTONE UBIQUITINATION; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PROTEIN ACETYLATION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CANDIDA ALBICANS; ENZYMOLOGY; METABOLISM; MYCOSIS; PHYSIOLOGY;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; FUNGAL PROTEINS; HISTONE DEMETHYLASES; HOST-PATHOGEN INTERACTIONS; HUMANS; LYSINE ACETYLTRANSFERASES; MYCOSES;

EID: 85002050685     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005938     Document Type: Review

References (165)

1. Brown G.D., et al., Hidden killers: human fungal infections. Sci Transl Med, 2012. 4(165): p. 165rv13. doi: 10.1126/scitranslmed.300440423253612
2. Pfaller M.A., Diekema D.J., Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev, 2007. 20(1): p. 133–63. doi: 10.1128/CMR.00029-0617223626
3. Kett D.H., et al., Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med, 2011. 39(4): p. 665–70. doi: 10.1097/CCM.0b013e318206c1ca21169817
4. Healey K.R., et al., Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nat Commun, 2016. 7: p. 11128. doi: 10.1038/ncomms1112827020939
5. Pfaller M.A., et al., Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol, 2012. 50(4): p. 1199–203. doi: 10.1128/JCM.06112-1122278842
6. Perlin D.S., Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.Drugs, 2014. 74(14): p. 1573–85. doi: 10.1007/s40265-014-0286-525255923
7. Perlroth J., Choi B., Spellberg B., Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol, 2007. 45(4): p. 321–46. doi: 10.1080/1369378070121868917510856
8. Wiederhold N.P., Patterson T.F., What's new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents. Curr Opin Infect Dis, 2015. 28(6): p. 539–45. doi: 10.1097/QCO.000000000000020326374950
9. Datta K., Hamad M., Immunotherapy of Fungal Infections. Immunol Invest, 2015. 44(8): p. 738–76. doi: 10.3109/08820139.2015.109391326575463
10. Levitz S.M., et al., Exploiting fungal cell wall components in vaccines. Semin Immunopathol, 2015. 37(2): p. 199–207. doi: 10.1007/s00281-014-0460-625404118
11. Nanjappa S.G., Klein B.S., Vaccine immunity against fungal infections. Curr Opin Immunol, 2014. 28: p. 27–33. doi: 10.1016/j.coi.2014.01.01424583636
12. Rai M.N., et al., Functional genomic analysis of Candida glabrata-macrophage interaction: role of chromatin remodeling in virulence. PLoS Pathog, 2012. 8(8): p. e1002863. doi: 10.1371/journal.ppat.100286322916016
13. Hnisz D., Tscherner M., Kuchler K., Targeting chromatin in fungal pathogens as a novel therapeutic strategy: histone modification gets infectious. Epigenomics, 2011. 3(2): p. 129–32. doi: 10.2217/epi.11.722122275
14. Lamoth F., Juvvadi P.R., Steinbach W.J., Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis. Front Microbiol, 2015. 6: p. 96. doi: 10.3389/fmicb.2015.0009625762988
15. Kouzarides T., Chromatin modifications and their function. Cell, 2007. 128(4): p. 693–705. doi: 10.1016/j.cell.2007.02.00517320507
16. Jenuwein T., Allis C.D., Translating the histone code. Science, 2001. 293(5532): p. 1074–80. doi: 10.1126/science.106312711498575
17. Smith E., Shilatifard A., The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Mol Cell, 2010. 40(5): p. 689–701. doi: 10.1016/j.molcel.2010.11.03121145479
18. Wang Q., et al., Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science, 2010. 327(5968): p. 1004–7. doi: 10.1126/science.117968720167787
19. Wu X., et al., Lysine acetylation is a widespread protein modification for diverse proteins in Arabidopsis. Plant Physiol, 2011. 155(4): p. 1769–78. doi: 10.1104/pp.110.16585221311030
20. Zhou X., et al., Systematic Analysis of the Lysine Acetylome in Candida albicans. J Proteome Res, 2016.
21. Weinert B.T., et al., Proteome-wide mapping of the Drosophila acetylome demonstrates a high degree of conservation of lysine acetylation. Sci Signal, 2011. 4(183): p. ra48. doi: 10.1126/scisignal.200190221791702
22. Zhao S., et al., Regulation of cellular metabolism by protein lysine acetylation. Science, 2010. 327(5968): p. 1000–4. doi: 10.1126/science.117968920167786
23. Yang X.J., Seto E., Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell, 2008. 31(4): p. 449–61. doi: 10.1016/j.molcel.2008.07.00218722172
24. Kouzarides T., Acetylation: a regulatory modification to rival phosphorylation?EMBO J, 2000. 19(6): p. 1176–9. doi: 10.1093/emboj/19.6.117610716917
25. Lopes da Rosa J., et al., Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis. Proc Natl Acad Sci U S A, 2010. 107(4): p. 1594–9. doi: 10.1073/pnas.091242710720080646
26. Wurtele H., et al., Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med, 2010. 16(7): p. 774–80. doi: 10.1038/nm.217520601951
27. Hnisz D., Schwarzmuller T., Kuchler K., Transcriptional loops meet chromatin: a dual-layer network controls white-opaque switching in Candida albicans. Mol Microbiol, 2009. 74(1): p. 1–15. doi: 10.1111/j.1365-2958.2009.06772.x19555456
28. Hnisz D., et al., The Set3/Hos2 histone deacetylase complex attenuates cAMP/PKA signaling to regulate morphogenesis and virulence of Candida albicans. PLoS Pathog, 2010. 6(5): p. e1000889. doi: 10.1371/journal.ppat.100088920485517
29. Hnisz D., et al., A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLoS Genet, 2012. 8(12): p. e1003118. doi: 10.1371/journal.pgen.100311823236295
30. Lu Y., Su C., Liu H., A GATA transcription factor recruits Hda1 in response to reduced Tor1 signaling to establish a hyphal chromatin state in Candida albicans. PLoS Pathog, 2012. 8(4): p. e1002663. doi: 10.1371/journal.ppat.100266322536157
31. Robbins N., Leach M.D., Cowen L.E., Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance. Cell Rep, 2012. 2(4): p. 878–88. doi: 10.1016/j.celrep.2012.08.03523041319
32. Stevenson J.S., Liu H., Regulation of white and opaque cell-type formation in Candida albicans by Rtt109 and Hst3. Mol Microbiol, 2011. 81(4): p. 1078–91. doi: 10.1111/j.1365-2958.2011.07754.x21749487
33. Srikantha T., et al., The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans. J Bacteriol, 2001. 183(15): p. 4614–25. doi: 10.1128/JB.183.15.4614-4625.200111443097
34. Lohse M.B., Johnson A.D., White-opaque switching in Candida albicans. Curr Opin Microbiol, 2009. 12(6): p. 650–4. doi: 10.1016/j.mib.2009.09.01019853498
35. Morschhauser J., Regulation of white-opaque switching in Candida albicans. Med Microbiol Immunol, 2010. 199(3): p. 165–72. doi: 10.1007/s00430-010-0147-020390300
36. Yang X., et al., Histone acetyltransferase 1 promotes homologous recombination in DNA repair by facilitating histone turnover. J Biol Chem, 2013. 288(25): p. 18271–82. doi: 10.1074/jbc.M113.47319923653357
37. Tscherner M., et al., The histone acetyltransferase Hat1 facilitates DNA damage repair and morphogenesis in Candida albicans. Mol Microbiol, 2012. 86(5): p. 1197–214. doi: 10.1111/mmi.1205123075292
38. Tscherner M., et al., The Candida albicans Histone Acetyltransferase Hat1 Regulates Stress Resistance and Virulence via Distinct Chromatin Assembly Pathways. PLoS Pathog, 2015. 11(10): p. e1005218. doi: 10.1371/journal.ppat.100521826473952
39. Nobile C.J., et al., A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans. MBio, 2014. 5(3): p. e01201–14. doi: 10.1128/mBio.01201-1424917598
40. Li X., et al., The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans. J Antimicrob Chemother, 2015. 70(7): p. 1993–2003. doi: 10.1093/jac/dkv07025825380
41. Chang P., Fan X., Chen J., Function and subcellular localization of Gcn5, a histone acetyltransferase in Candida albicans. Fungal Genet Biol, 2015. 81: p. 132–41. doi: 10.1016/j.fgb.2015.01.01125656079
42. Kim S.C., et al., Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell, 2006. 23(4): p. 607–18. doi: 10.1016/j.molcel.2006.06.02616916647
43. Chauhan N., Two-component phosphorelays in fungal mitochondria and beyond. Mitochondrion, 2015. 22: p. 60–5. doi: 10.1016/j.mito.2015.03.00325858273
44. Shingu-Vazquez M., Traven A., Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy. Eukaryot Cell, 2011. 10(11): p. 1376–83. doi: 10.1128/EC.05184-1121926328
45. Seider K., et al., The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol, 2011. 187(6): p. 3072–86. doi: 10.4049/jimmunol.100373021849684
46. Tierney L., et al., An Interspecies Regulatory Network Inferred from Simultaneous RNA-seq of Candida albicans Invading Innate Immune Cells. Front Microbiol, 2012. 3: p. 85. doi: 10.3389/fmicb.2012.0008522416242
47. Ribet D., Cossart P., Pathogen-mediated posttranslational modifications: A re-emerging field. Cell, 2010. 143(5): p. 694–702. doi: 10.1016/j.cell.2010.11.01921111231
48. Adam T., et al., Cytoskeletal rearrangements and the functional role of T-plastin during entry of Shigella flexneri into HeLa cells. J Cell Biol, 1995. 129(2): p. 367–81. 7721941
49. Berndtson K., Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med, 2013. 6: p. 291–306. doi: 10.2147/IJGM.S4411423637552
50. Rupp J., et al., Chlamydia pneumoniae hides inside apoptotic neutrophils to silently infect and propagate in macrophages. PLoS One, 2009. 4(6): p. e6020. doi: 10.1371/journal.pone.000602019547701
51. Cowen L.E., et al., Mechanisms of Antifungal Drug Resistance. Cold Spring Harb Perspect Med, 2015. 5(7): p. a019752.
52. Alexander B.D., et al., Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis, 2013. 56(12): p. 1724–32. doi: 10.1093/cid/cit13623487382
53. Bolden J.E., Peart M.J., Johnstone R.W., Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov, 2006. 5(9): p. 769–84. doi: 10.1038/nrd213316955068
54. Kazantsev A.G., Thompson L.M., Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov, 2008. 7(10): p. 854–68. doi: 10.1038/nrd268118827828
55. Xu W.S., Parmigiani R.B., Marks P.A., Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene, 2007. 26(37): p. 5541–52. doi: 10.1038/sj.onc.121062017694093
56. Pfaller M.A., et al., Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens. J Clin Microbiol, 2009. 47(12): p. 3797–804. doi: 10.1128/JCM.00618-0919794038
57. Pfaller M.A., et al., In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species. Diagn Microbiol Infect Dis, 2015. 81(4):259–263. doi: 10.1016/j.diagmicrobio.2014.11.00825600842
58. Lamoth F., et al., Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus. Antimicrob Agents Chemother, 2014. 58(4): p. 1889–96. doi: 10.1128/AAC.02286-1324395240
59. Li X., et al., Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans. Antimicrob Agents Chemother, 2015. 59(10): p. 5885–91. doi: 10.1128/AAC.00726-1526195510
60. Majer O., et al., Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog, 2012. 8(7): p. e1002811. doi: 10.1371/journal.ppat.100281122911155
61. Zwolanek F., et al., The non-receptor tyrosine kinase Tec controls assembly and activity of the noncanonical caspase-8 inflammasome. PLoS Pathog, 2014. 10(12): p. e1004525. doi: 10.1371/journal.ppat.100452525474208
62. Wirnsberger G., et al., Inhibition of CBLB protects from lethal Candida albicans sepsis. Nat Med, 2016.
63. Min K., et al., Candida albicans Gene Deletion with a Transient CRISPR-Cas9 System. mSphere, 2016. 1(3).
64. Tierney L., et al., Systems biology of host-fungus interactions: turning complexity into simplicity. Curr Opin Microbiol, 2012. 15(4): p. 440–6. doi: 10.1016/j.mib.2012.05.00122717554
65. Harr J.C., Gonzalez-Sandoval A., Gasser S.M., Histones and histone modifications in perinuclear chromatin anchoring: from yeast to man. EMBO Rep, 2016. 17(2): p. 139–55. doi: 10.15252/embr.20154180926792937
66. Waters R., van Eijk P., Reed S., Histone modification and chromatin remodeling during NER. DNA Repair (Amst), 2015. 36: p. 105–13.
67. Dahlin J.L., et al., Histone-modifying enzymes, histone modifications and histone chaperones in nucleosome assembly: Lessons learned from Rtt109 histone acetyltransferases. Crit Rev Biochem Mol Biol, 2015. 50(1): p. 31–53. doi: 10.3109/10409238.2014.97897525365782
68. Xiong B., Lu S., Gerton J.L., Hos1 is a lysine deacetylase for the Smc3 subunit of cohesin. Curr Biol, 2010. 20(18): p. 1660–5. doi: 10.1016/j.cub.2010.08.01920797861
69. Robyr D., et al., Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases. Cell, 2002. 109(4): p. 437–46. 12086601
70. Yang X.J., Seto E., The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol, 2008. 9(3): p. 206–18. doi: 10.1038/nrm234618292778
71. Wang A., Kurdistani S.K., Grunstein M., Requirement of Hos2 histone deacetylase for gene activity in yeast. Science, 2002. 298(5597): p. 1412–4. doi: 10.1126/science.107779012434058
72. Chen X., et al., Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci U S A, 2012. 109(42): p. E2865–74. doi: 10.1073/pnas.112113110922802645
73. Karthikeyan G., et al., Functional characterization of Candida albicans Hos2 histone deacetylase. F1000Res, 2013. 2: p. 238. doi: 10.12688/f1000research.2-238.v325110576
74. Millar C.B., Grunstein M., Genome-wide patterns of histone modifications in yeast. Nat Rev Mol Cell Biol, 2006. 7(9): p. 657–666. doi: 10.1038/nrm198616912715
75. Ahn S.H., et al., Histone H2B deacetylation at lysine 11 is required for yeast apoptosis induced by phosphorylation of H2B at serine 10. Mol Cell, 2006. 24(2): p. 211–20. doi: 10.1016/j.molcel.2006.09.00817052455
76. Carmen A.A., et al., Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity. Proc Natl Acad Sci U S A, 1999. 96(22): p. 12356–61. 10535926
77. Trojer P., et al., Histone deacetylases in fungi: novel members, new facts. Nucleic Acids Res, 2003. 31(14): p. 3971–81. 12853613
78. Chang C.S., Pillus L., Collaboration between the essential Esa1 acetyltransferase and the Rpd3 deacetylase is mediated by H4K12 histone acetylation in Saccharomyces cerevisiae. Genetics, 2009. 183(1): p. 149–60. doi: 10.1534/genetics.109.10384619596907
79. Rundlett S.E., et al., HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc Natl Acad Sci U S A, 1996. 93(25): p. 14503–8. 8962081
80. Suka N., et al., Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol Cell, 2001. 8(2): p. 473–9. 11545749
81. Bernstein B.E., Tong J.K., Schreiber S.L., Genomewide studies of histone deacetylase function in yeast. Proc Natl Acad Sci U S A, 2000. 97(25): p. 13708–13. doi: 10.1073/pnas.25047769711095743
82. Brosch G., Loidl P., Graessle S., Histone modifications and chromatin dynamics: a focus on filamentous fungi. FEMS Microbiol Rev, 2008. 32(3): p. 409–39. doi: 10.1111/j.1574-6976.2007.00100.x18221488
83. Mai A., et al., Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans. Bioorg Med Chem Lett, 2007. 17(5): p. 1221–5. doi: 10.1016/j.bmcl.2006.12.02817196388
84. Robert T., et al., HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature, 2011. 471(7336): p. 74–9. doi: 10.1038/nature0980321368826
85. Kurdistani S.K., Grunstein M., Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol, 2003. 4(4): p. 276–84. doi: 10.1038/nrm107512671650
86. Wu J., et al., TUP1 utilizes histone H3/H2B-specific HDA1 deacetylase to repress gene activity in yeast. Mol Cell, 2001. 7(1): p. 117–26. 11172717
87. Klar A.J., Srikantha T., Soll D.R., A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans. Genetics, 2001. 158(2): p. 919–24. 11404352
88. Vogelauer M., et al., Global histone acetylation and deacetylation in yeast. Nature, 2000. 408(6811): p. 495–8. doi: 10.1038/3504412711100734
89. Simonetti G., et al., Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. FEMS Yeast Res, 2007. 7(8): p. 1371–80. doi: 10.1111/j.1567-1364.2007.00276.x17627775
90. Grozinger C.M., Hassig C.A., Schreiber S.L., Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A, 1999. 96(9): p. 4868–73. 10220385
91. Bjerling P., et al., Functional divergence between histone deacetylases in fission yeast by distinct cellular localization and in vivo specificity. Mol Cell Biol, 2002. 22(7): p. 2170–81. doi: 10.1128/MCB.22.7.2170-2181.200211884604
92. Ekwall K., Genome-wide analysis of HDAC function. Trends Genet, 2005. 21(11): p. 608–15. doi: 10.1016/j.tig.2005.08.00916153738
93. Weber J.M., Irlbacher H., Ehrenhofer-Murray A.E., Control of replication initiation by the Sum1/Rfm1/Hst1 histone deacetylase. BMC Mol Biol, 2008. 9: p. 100. doi: 10.1186/1471-2199-9-10018990212
94. Jing H., Lin H., Sirtuins in epigenetic regulation. Chem Rev, 2015. 115(6): p. 2350–75. doi: 10.1021/cr500457h25804908
95. Robert F., et al., Global position and recruitment of HATs and HDACs in the yeast genome. Mol Cell, 2004. 16(2): p. 199–209. doi: 10.1016/j.molcel.2004.09.02115494307
96. Avalos J.L., Bever K.M., Wolberger C., Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell, 2005. 17(6): p. 855–68. doi: 10.1016/j.molcel.2005.02.02215780941
97. Madsen C.T., et al., Biotin starvation causes mitochondrial protein hyperacetylation and partial rescue by the SIRT3-like deacetylase Hst4p. Nat Commun, 2015. 6: p. 7726. doi: 10.1038/ncomms872626158509
98. Vaquero A., The conserved role of sirtuins in chromatin regulation. Int J Dev Biol, 2009. 53(2–3): p. 303–22. doi: 10.1387/ijdb.082675av19378253
99. Michan S., Sinclair D., Sirtuins in mammals: insights into their biological function. Biochem J, 2007. 404(1): p. 1–13. doi: 10.1042/BJ2007014017447894
100. Gaglio D., D'Alfonso A., Camilloni G., Functional complementation of sir2Delta yeast mutation by the human orthologous gene SIRT1. PLoS One, 2013. 8(12): p. e83114. doi: 10.1371/journal.pone.008311424349441
101. Celic I., et al., The sirtuins hst3 and Hst4p preserve genome integrity by controlling histone h3 lysine 56 deacetylation. Curr Biol, 2006. 16(13): p. 1280–9. doi: 10.1016/j.cub.2006.06.02316815704
102. Saunders L.R., Verdin E., Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene, 2007. 26(37): p. 5489–504. doi: 10.1038/sj.onc.121061617694089
103. Dang W., et al., Histone H4 lysine 16 acetylation regulates cellular lifespan. Nature, 2009. 459(7248): p. 802–7. doi: 10.1038/nature0808519516333
104. Bedalov A., et al., Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci U S A, 2001. 98(26): p. 15113–8. doi: 10.1073/pnas.26157439811752457
105. Raman S.B., et al., Candida albicans SET1 encodes a histone 3 lysine 4 methyltransferase that contributes to the pathogenesis of invasive candidiasis. Mol Microbiol, 2006. 60(3): p. 697–709. doi: 10.1111/j.1365-2958.2006.05121.x16629671
106. Boa S., Coert C., Patterton H.G., Saccharomyces cerevisiae Set1p is a methyltransferase specific for lysine 4 of histone H3 and is required for efficient gene expression. Yeast, 2003. 20(9): p. 827–35. doi: 10.1002/yea.99512845608
107. Greer E.L., Shi Y., Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet, 2012. 13(5): p. 343–57. doi: 10.1038/nrg317322473383
108. Pokholok D.K., et al., Genome-wide map of nucleosome acetylation and methylation in yeast. Cell, 2005. 122(4): p. 517–27. doi: 10.1016/j.cell.2005.06.02616122420
109. Ahn S.H., et al., Sterile 20 kinase phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced apoptosis in S. cerevisiae. Cell, 2005. 120(1): p. 25–36. doi: 10.1016/j.cell.2004.11.01615652479
110. Cheung W.L., et al., Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell, 2003. 113(4): p. 507–17. 12757711
111. Leberer E., et al., Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci U S A, 1996. 93(23): p. 13217–22. 8917571
112. Xiong W., et al., Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors. Mol Cancer Ther, 2016. 15(3): p. 412–20. doi: 10.1158/1535-7163.MCT-15-070326721946
113. Rossetto D., Avvakumov N., Cote J., Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics, 2012. 7(10): p. 1098–108. doi: 10.4161/epi.2197522948226
114. Rando O.J., Winston F., Chromatin and transcription in yeast. Genetics, 2012. 190(2): p. 351–87. doi: 10.1534/genetics.111.13226622345607
115. Ward I.M., Chen J., Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem, 2001. 276(51): p. 47759–62. doi: 10.1074/jbc.C10056920011673449
116. Tuleva B., Vasileva-Tonkova E., Galabova D., A specific alkaline phosphatase from Saccharomyces cerevisiae with protein phosphatase activity. FEMS Microbiol Lett, 1998. 161(1): p. 139–44. 9561742
117. Noble S.M., et al., Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat Genet, 2010. 42(7): p. 590–8. doi: 10.1038/ng.60520543849
118. Cieniewicz A.M., et al., The bromodomain of Gcn5 regulates site specificity of lysine acetylation on histone H3. Mol Cell Proteomics, 2014. 13(11): p. 2896–2910. doi: 10.1074/mcp.M114.03817425106422
119. Agalioti T., Chen G., Thanos D., Deciphering the Transcriptional Histone Acetylation Code for a Human Gene. Cell, 2002. 111(3): p. 381–392. 12419248
120. Grant P.A., et al., Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev, 1997. 11(13): p. 1640–509224714
121. Balasubramanyam K., Altaf M., Varier R.A., Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem, 2004. 279(32):33716–26doi: 10.1074/jbc.M40283920015155757
122. O'Meara T.R., et al., Cryptococcus neoformans Histone Acetyltransferase Gcn5 Regulates Fungal Adaptation to the Host. Eukaryot Cell, 2010. 9(8): p. 11931202.
123. Dekker F.J., Ghizzoni M., van der Meer N., Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones. Bioorg Med Chem, 2009. 17(2): p. 460–6. doi: 10.1016/j.bmc.2008.12.00819111471
124. Dekker F.J., Haisma H.J., Histone acetyl transferases as emerging drug targets. Drug Discov Today, 2009. 14(19–20): p. 942–948. doi: 10.1016/j.drudis.2009.06.00819577000
125. Ruotolo R., et al., Chemogenomic profiling of the cellular effects associated with histone H3 acetylation impairment by a quinoline-derived compound. Genomics, 2010. 96(5): p. 272–280. doi: 10.1016/j.ygeno.2010.08.00520732410
126. Chimenti F., et al., A novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4'-chlorophenyl)thiazol-2-ylhydrazone. J Med Chem, 2009. 52(2): p. 530–536. doi: 10.1021/jm800885d19099397
127. Jeon J., Kwon S., Lee Y.H., Histone acetylation in fungal pathogens of plants. Plant Pathol J, 2014. 30(1): p. 1–9doi: 10.5423/PPJ.RW.01.2014.000325288980
128. Kleff S., et al., Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem, 1995. 270(42): p. 24674–24677. 7559580
129. Sobel R.E., et al., Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci U S A, 1995. 92(4): p. 1237–1241. 7862667
130. Shah P., et al., The Aspergillus Genome Database (AspGD): recent developments in comprehensive multispecies curation, comparative genomics and community resources. Nucleic Acids Res, 2012. 40: p. D653–9doi: 10.1093/nar/gkr87522080559
131. Tafrova J.I., Tafrov S.T., Human histone acetyltransferase 1 (Hat1) acetylates lysine 5 of histone H2A in vivo. Mol Cell Biochem, 2014. 392(1–2): p. 259–272. doi: 10.1007/s11010-014-2036-024682716
132. Makowski A.M., Dutnall R.N., Annunziato A.T., Effects of acetylation of histone H4 at lysines 8 and 16 on activity of the Hat1 histone acetyltransferase. J Biol Chem, 2001. 276(47): p. 43499–43502. doi: 10.1074/jbc.C10054920011585814
133. Winkler S.G., et al., Elongator is a histone H3 and H4 acetyltransferase important for normal histone acetylation levels in vivo. Proc Natl Acad Sci U S A, 2002. 99(6): p. 3517–3522. doi: 10.1073/pnas.02204289911904415
134. Li F., et al., The Elp3 subunit of human Elongator complex is functionally similar to its counterpart in yeast. Mol Genet Genomics, 2005. 273(3): p. 264–272. doi: 10.1007/s00438-005-1120-215902492
135. Sampath V., et al., Biochemical characterization of Hpa2 and Hpa3, two small closely related acetyltransferases from Saccharomyces cerevisiae. J Biol Chem, 2013. 288(30): p. 21506–21513. doi: 10.1074/jbc.M113.48627423775086
136. Angus-Hill M.L., et al., Crystal structure of the histone acetyltransferase Hpa2: A tetrameric member of the Gcn5-related N-acetyltransferase superfamily. J Mol Biol, 1999. 294(5): p. 1311–1325. doi: 10.1006/jmbi.1999.333810600387
137. Lorch Y., et al., Mediator-nucleosome interaction. Molecular cell, 2000. 6(1): p. 197–201. 10949041
138. Zhu X., et al., Mediator influences telomeric silencing and cellular life span. Mol Cell Biol, 2011. 31(12): p. 2413–2421. doi: 10.1128/MCB.05242-1121482672
139. Wang X., et al., Distinct and redundant roles of the two MYST histone acetyltransferases Esa1 and Sas2 in cell growth and morphogenesis of Candida albicans. Eukaryot Cell, 2013. 12(3): p. 438–449. doi: 10.1128/EC.00275-1223355007
140. Allard S., et al., NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J, 1999. 18(18): p. 5108–5119. doi: 10.1093/emboj/18.18.510810487762
141. Coffey K., et al., Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. PloS One, 2012. 7(10).
142. Kimura A., Umehara T., Horikoshi M., Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing. Nat Genet, 2002. 32(3): p. 370–377. doi: 10.1038/ng99312410229
143. Suka N., Luo K., Grunstein M., Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin. Nat Genet, 2002. 32(3): p. 378–383. doi: 10.1038/ng101712379856
144. Su J., et al., The Functional Analysis of Histone Acetyltransferase MOF in Tumorigenesis. Int J Mol Sci, 2016. 17(1): p. 99.
145. Rosaleny L.E., et al., The Sas3p and Gcn5p histone acetyltransferases are recruited to similar genes. Genome Biol, 2007. 8(6) p. 119.
146. Howe L., et al., Histone H3 specific acetyltransferases are essential for cell cycle progression. Genes Dev, 2001. 15:3144doi: 10.1101/gad.93140111731478
147. Song O.-K.K., et al., An Nalpha-acetyltransferase responsible for acetylation of the N-terminal residues of histones H4 and H2A. J Biol Chem, 2003. 278(40): p. 38109–38112. doi: 10.1074/jbc.C30035520012915400
148. Hole K., et al., The human N-alpha-acetyltransferase 40 (hNaa40p/hNatD) is conserved from yeast and N-terminally acetylates histones H2A and H4. PloS One, 2011. 6(9) p. e24713. doi: 10.1371/journal.pone.002471321935442
149. Mizzen C.A., et al., The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell, 1996. 87(7): p. 1261–1270. 8980232
150. Kimura A., Matsubara K., Horikoshi M., A decade of histone acetylation: marking eukaryotic chromosomes with specific codes. J Biochem, 2005. 138(6): p. 647–662. doi: 10.1093/jb/mvi18416428293
151. Driscoll R., Hudson A., Jackson S.P., Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56. Science, 2007. 315(5812): p. 649–652. doi: 10.1126/science.113586217272722
152. Han J., et al., Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication. Science, 2007.315(5812): p. 653–655. doi: 10.1126/science.113323417272723
153. Schneider J., et al., Rtt109 Is Required for Proper H3K56 Acetylation A chromatin mark associated with the elongating RNA polymerase II. J Biol Chem, 2006. 281(49):37270–4. doi: 10.1074/jbc.C60026520017046836
154. Das C., et al., CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature, 2009. 459(7243): p. 113–117. doi: 10.1038/nature0786119270680
155. Balasubramanyam K., et al., Small molecule modulators of histone acetyltransferase p300. J Biol Chem, 2003. 278(21): p. 19134–19140. doi: 10.1074/jbc.M30158020012624111
156. Carradori S., et al., Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies. Eur J Med Chem, 2014. 80: p. 569–578. doi: 10.1016/j.ejmech.2014.04.04224835815
157. Chatterjee S., et al., A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice. J Neurosci, 2013. 33(26): p. 10698–10712. doi: 10.1523/JNEUROSCI.5772-12.201323804093
158. Bowers E.M., et al., Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor. Chem Biol, 2010. 17(5): p. 471–482. doi: 10.1016/j.chembiol.2010.03.00620534345
159. Schram A.W., et al., A dual role for SAGA-associated factor 29 (SGF29) in ER stress survival by coordination of both histone H3 acetylation and histone H3 lysine-4 trimethylation. PloS One, 2013. 8(7): p. e70035. doi: 10.1371/journal.pone.007003523894581
160. Xu F., Zhang K., Grunstein M., Acetylation in histone H3 globular domain regulates gene expression in yeast. Cell, 2005. 121(3): p. 375–385. doi: 10.1016/j.cell.2005.03.01115882620
161. Lee J-EE, Oh J-HH, Ku M, Kim J, Lee J-SS, et al. Ssn6 has dual roles in Candida albicans filament development through the interaction with Rpd31. FEBS Lett, 2015. 589: 513–20. doi: 10.1016/j.febslet.2015.01.01125601565
162. Davie J.R., Inhibition of histone deacetylase activity by butyrate. J Nutr, 2003. 133: 2485S–2493S. 12840228
163. Scholz C., Acetylation site specificities of lysine deacetylase inhibitors in human cells. Nat Biotech, 2015. 33: 415–423.
164. Grozinger C.M., Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem, 2001. 276: 38837–38843. doi: 10.1074/jbc.M10677920011483616
165. Dekker F.J., van den Bosch T., Martin N.I., Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases. Drug Discov Today, 2014. 19: 654–660. doi: 10.1016/j.drudis.2013.11.01224269836